Cite
HARVARD Citation
Tegenge, M. et al. (2019). Clinical Pharmacology Review of Plasma‐derived and Recombinant Protein Products: CBER Experience and Perspectives on Model‐Informed Drug Development. Haemophilia. 25 (4), pp. e240-e246. [Online].